See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:CASI
Delisted

Casi Pharmaceuticals Stock News

etoro logo Buy CASI
*Your capital is at risk
$0.208
+0 (+0%)
At Close: May 22, 2026
Forecast Financials Insider Trading Signals Historical Prices Predictions News Profile

CASI Pharmaceuticals Announces Third Quarter 2019 Financial Results

 12:00pm, Tuesday, 12'th Nov 2019
ROCKVILLE, Md. and BEIJING , Nov. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharm

CASI Pharmaceuticals Q3 EPS $(0.1), Same YoY

 12:00am, Tuesday, 12'th Nov 2019

CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement For Octreotide Long Acting Injectable (LAI) Microsphere For Neuroendocrine Cancers And Acromegaly

 12:00pm, Thursday, 07'th Nov 2019
ROCKVILLE, Md. and BEIJING, Nov. 7, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and phar

CASI Pharmaceuticals Enters Exclusive Distribution Agreement With Pharmathen Global BV For The Development And Distribution Of Octreotide Long Acting Injectable Microsphere In China.

 12:00am, Thursday, 07'th Nov 2019

Ligand's (LGND) Q3 Earnings Miss Estimates, EPS View Down

 02:33pm, Wednesday, 06'th Nov 2019
Ligand (LGND) reports lower-than-expected third-quarter 2019 earnings. It also lowers outlook for 2019 earnings. However, revenues were better than expected.

Ligand's (LGND) Q3 Earnings Miss Estimates, EPS View Down

 12:00am, Wednesday, 06'th Nov 2019

CASI Pharma 8-K Shows Co. Entered Exclusive License Distribution License Deal With Pharmathen To Develop, Distribute Octreotide Long-Acting Injectable Microsphere In China

 12:00am, Friday, 01'st Nov 2019

Week In Review: Investor Group Bids $4.6 Billion To Acquire China Biologic

 12:00am, Saturday, 21'st Sep 2019

New president at CASI Pharma

 12:00am, Thursday, 19'th Sep 2019

CASI Pharma Reports China's National Medical Product Administration Accepted Trial Application For Co.'s CD19 CAR-T Product

 12:00am, Monday, 16'th Sep 2019

CASI Pharmaceuticals (CASI) Investor Presentation - Slideshow

 12:00am, Tuesday, 10'th Sep 2019

Ligand Pharma Reports Partnership With CASI Pharma To Launch EVOMELA in China

 12:00am, Monday, 12'th Aug 2019

CASI Pharmaceuticals Q2 EPS $(0.16) Down From $(0.07) YoY

 12:00am, Friday, 09'th Aug 2019

Week In Review: Immunotherapies Dominate The Week's China Biopharma News

 12:00am, Saturday, 22'nd Jun 2019

CASI Pharma Acquires Worldwide Rights to Commercialize Anti-CD19 T-Cell Therapy From Juventas Cell Therapy, CASI to Invest RMB 80M in Juventas

 12:00am, Monday, 17'th Jun 2019
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE